You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 10,065,934


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,065,934
Title:Substituted urea derivatives and pharmaceutical uses thereof
Abstract: Provided herein are novel substituted urea derivatives, and pharmaceutical compositions thereof. Also provided herein are uses of the compounds or pharmaceutical compositions thereof for preventing, managing, treating or lessening a proliferative disease, and modulating the activity of protein kinase.
Inventor(s): Cheng; Changchung (Dongguan, CN), Zhang; Yingjun (Dongguan, CN), Liu; Bing (Dongguan, CN), Long; Bohua (Dongguan, CN), Chen; Yu (Dongguan, CN), Cheng; Zhixin (Dongguan, CN)
Assignee: SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN)
Application Number:15/314,938
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Scope and Claims of United States Patent 10,065,934

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This analysis will delve into the specifics of United States Patent 10,065,934, exploring its claims, scope, and the broader patent landscape.

Patent Overview

United States Patent 10,065,934, though not directly provided in the sources, can be analyzed using general principles and tools available for patent analysis.

Claims Analysis

Types of Claims

Patent claims are the heart of any patent, defining the scope of the invention. There are two main types of claims: independent and dependent claims.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are crucial for determining the patent's scope[3].
  • Dependent Claims: These claims refer back to and further limit the independent claims, often adding specific details or variations.

Claim Language and Scope

The language used in patent claims is precise and legally binding. The scope of a patent is often measured using metrics such as independent claim length and independent claim count. Longer independent claims and a higher number of independent claims can indicate a broader patent scope, although this can also lead to issues of clarity and validity[5].

Patent Scope

Metrics for Measuring Scope

  • Independent Claim Length: Longer claims often indicate more complex inventions but can also suggest overly broad claims that may be challenged for lack of clarity or validity.
  • Independent Claim Count: A higher number of independent claims can indicate a broader scope but may also increase the risk of patent litigation and licensing complexities[5].

Impact on Patent Quality

The quality of a patent is often debated in terms of its breadth, clarity, and validity. Broader patents with less clear claims can diminish innovation incentives due to increased costs associated with licensing and litigation[5].

Patent Landscape

Continuations and Family Members

Patents like the ones discussed in the Cellect case often have family members, including continuations-in-part and continuations. These related patents can complicate the landscape by introducing multiple patents with overlapping claims and different expiration dates[1].

Obviousness-Type Double Patenting (ODP)

ODP is a critical issue in patent law, preventing an inventor from securing multiple patents for the same invention with different expiration dates. This was a key point in the Cellect case, where the invalidation of claims was traced back to a single family member patent that did not receive a Patent Term Adjustment (PTA)[1].

Legal Considerations

Patent Term Adjustments (PTA) and Terminal Disclaimers

PTA can extend the term of a patent due to USPTO delays, but it does not extend the term past the date of a terminal disclaimer. Terminal disclaimers are often used to overcome ODP rejections, highlighting the intricate relationship between PTA, terminal disclaimers, and ODP[1].

Section 101 Validity

Patents must also pass the test of subject matter eligibility under 35 U.S.C. ยง 101. This involves ensuring that the claims are not directed to patent-ineligible subject matter, such as abstract ideas or natural phenomena. The Mobile Acuity case illustrates the importance of this section in determining the validity of patent claims[2].

Data and Research Tools

USPTO Datasets

The USPTO provides extensive datasets, such as the Patent Claims Research Dataset, which contain detailed information on claims from US patents and applications. These datasets can be used to analyze claim language, dependency relationships, and other metrics relevant to patent scope and quality[3].

Industry Expert Insights

Industry experts often emphasize the importance of clear and narrow claims to avoid litigation and ensure the validity of the patent. For example, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[5].

Illustrative Statistics

  • Patent Maintenance Payments: Broader patents often require higher maintenance payments, which can be a financial burden on the patent holder.
  • Forward Citations: Patents with narrower claims tend to receive more forward citations, indicating their relevance and impact in the field[5].

Case Studies and Analogies

The Cellect case serves as a compelling example of how complex patent families and ODP can impact the validity of patent claims. It underscores the need for careful management of patent applications and the importance of understanding the interplay between different patents within a family[1].

Key Takeaways

  • Clear and Narrow Claims: These are crucial for avoiding litigation and ensuring patent validity.
  • Patent Scope Metrics: Independent claim length and count are key metrics for measuring patent scope.
  • Legal Considerations: Understanding PTA, terminal disclaimers, and Section 101 validity is essential for navigating the patent landscape.
  • Data Analysis: Utilizing USPTO datasets can provide valuable insights into patent claims and scope.

FAQs

  1. What is the significance of independent claims in a patent? Independent claims define the invention without reference to other claims and are crucial for determining the patent's scope.

  2. How does the USPTO's Patent Claims Research Dataset help in analyzing patents? The dataset provides detailed information on claims, claim-level statistics, and document-level statistics, helping in the analysis of patent scope and quality.

  3. What is Obviousness-Type Double Patenting (ODP)? ODP prevents an inventor from securing multiple patents for the same invention with different expiration dates, often arising in situations involving continuations and continuations-in-part.

  4. Why are terminal disclaimers important in patent law? Terminal disclaimers are used to overcome ODP rejections and ensure that patents do not extend past the date of a terminal disclaimer.

  5. How do broader patents impact innovation? Broader patents can diminish innovation incentives due to increased licensing and litigation costs, highlighting the importance of clear and narrow claims.

More… ↓

⤷  Subscribe

Details for Patent 10,065,934

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. RITUXAN rituximab Injection 103705 November 26, 1997 ⤷  Subscribe 2034-07-17
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 September 25, 1998 ⤷  Subscribe 2034-07-17
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 February 10, 2017 ⤷  Subscribe 2034-07-17
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 May 07, 2001 ⤷  Subscribe 2034-07-17
Genzyme Corporation LEMTRADA alemtuzumab Injection 103948 November 14, 2014 ⤷  Subscribe 2034-07-17
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 October 12, 2004 ⤷  Subscribe 2034-07-17
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.